BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35113279)

  • 1. Comparison of the incidence rates of hip and vertebral fragility fractures according to cataract surgery in elderly population: a nationwide cohort study.
    Lim JY; Yoo JI; Kim RB; Koo HJ; Kong GM; Ha YC
    Arch Osteoporos; 2022 Feb; 17(1):30. PubMed ID: 35113279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of four major types of osteoporotic fragility fractures among elderly individuals in Sado, Japan, in 2015.
    Imai N; Endo N; Shobugawa Y; Oinuma T; Takahashi Y; Suzuki K; Ishikawa Y; Makino T; Suzuki H; Miyasaka D; Sakuma M
    J Bone Miner Metab; 2019 May; 37(3):484-490. PubMed ID: 29956020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of vertebral fractures in elderly women with recent hip fractures: the BREAK Study.
    Gonnelli S; Caffarelli C; Maggi S; Rossi S; Siviero P; Gandolini G; Cisari C; Rossini M; Iolascon G; Letizia Mauro G; Crepaldi G; Nuti R;
    Osteoporos Int; 2013 Apr; 24(4):1151-9. PubMed ID: 23011681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.
    Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK
    Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Frailty in Patients Admitted to Hospital with Vertebral Fragility Fractures.
    Walters S; Chan S; Goh L; Ong T; Sahota O
    Curr Rheumatol Rev; 2016; 12(3):244-247. PubMed ID: 27323881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of outcomes and management of patients post fragility fractures in China.
    Wang O; Hu Y; Gong S; Xue Q; Deng Z; Wang L; Liu H; Tang H; Guo X; Chen J; Jia X; Xu Y; Lan L; Lei C; Dong H; Yuan G; Fu Q; Wei Y; Xia W; Xu L
    Osteoporos Int; 2015 Nov; 26(11):2631-40. PubMed ID: 25966892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Nottingham Spinal Health (NoSH) Study: a cohort study of patients hospitalised with vertebral fragility fractures.
    Ong T; Sahota O; Gladman JRF
    Osteoporos Int; 2020 Feb; 31(2):363-370. PubMed ID: 31696271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    Nakatoh S; Fujimori K; Ishii S; Tamaki J; Okimoto N; Ogawa S; Iki M
    Arch Osteoporos; 2021 Sep; 16(1):130. PubMed ID: 34510296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent Fragility Fractures: A Cross-sectional Analysis.
    Dang DY; Zetumer S; Zhang AL
    J Am Acad Orthop Surg; 2019 Jan; 27(2):e85-e91. PubMed ID: 30169444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55 to 90 Years Presenting With a Fragility Fracture.
    Toth E; Banefelt J; Åkesson K; Spångeus A; Ortsäter G; Libanati C
    J Bone Miner Res; 2020 May; 35(5):861-868. PubMed ID: 31914206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Beall DP; Feldman RG; Gordon ML; Gruber BL; Lane JM; Valenzuela G; Yim D; Alam J; Krege JH; Krohn K
    Osteoporos Int; 2016 Mar; 27(3):1191-1198. PubMed ID: 26556737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis.
    Tsukutani Y; Hagino H; Ito Y; Nagashima H
    Osteoporos Int; 2015 Sep; 26(9):2249-55. PubMed ID: 25986382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Incident Major Osteoporotic and Hip Fractures by Trabecular Bone Score (TBS) and Prevalent Radiographic Vertebral Fracture in Older Men.
    Schousboe JT; Vo T; Taylor BC; Cawthon PM; Schwartz AV; Bauer DC; Orwoll ES; Lane NE; Barrett-Connor E; Ensrud KE;
    J Bone Miner Res; 2016 Mar; 31(3):690-7. PubMed ID: 26378772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting of vertebral fragility fractures: can radiologists help reduce the number of hip fractures?
    Mitchell RM; Jewell P; Javaid MK; McKean D; Ostlere SJ
    Arch Osteoporos; 2017 Dec; 12(1):71. PubMed ID: 28785996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and mortality of subsequent vertebral fractures: analysis of claims data of the Korea National Health Insurance Service from 2007 to 2016.
    Park SM; Ahn SH; Kim HY; Jang S; Ha YC; Lee YK; Chung HY
    Spine J; 2020 Feb; 20(2):225-233. PubMed ID: 31589928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of survival rates for hip fracture patients with or without subsequent osteoporotic vertebral compression fractures.
    Angthong C; Angthong W; Harnroongroj T; Harnroongroj T
    Tohoku J Exp Med; 2012 Feb; 226(2):129-35. PubMed ID: 22277326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Cholecystectomy and the Risk for Fracture: A Nationwide Population-Based Cohort Study in Korea.
    Lee EJ; Shin CM; Lee DH; Han K; Park SH; Kim YJ; Yoon H; Park YS; Kim N
    Front Endocrinol (Lausanne); 2021; 12():657488. PubMed ID: 34122336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
    Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.